Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01907061 · ClinicalTrials.gov registry record · NA
Acute Renal Failure Post Liver Transplantation
A NA study of Acute Renal Failure, sponsored by Baylor Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01907061 is a NA study of Acute Renal Failure that has completed, run by Baylor Research Institute. The registered enrollment target is 30 participants, below the 262-participant average among 5 other Acute Renal Failure trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01907061, a NA study of Acute Renal Failure, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Trial to test the effect of administering N-acetylcysteine on cytokines and markers of oxidant stress and the incidence of acute renal failure post liver tranplant
Conditions Studied
Interventions
- DRUG Placebo
- DRUG N-acetylcysteine
Study Locations (1)
Texas
- Annette C. and Harold C. Simmons Tranplant Institute at Baylor Medical Center Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-07 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01907061
The ClinicalTrials.gov registry entry for NCT01907061 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 262-participant average among 5 other Acute Renal Failure trials with a reported enrollment target (89% lower). The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Renal Failure appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01907061 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01907061 about?
NCT01907061 is a clinical study titled "Acute Renal Failure Post Liver Transplantation". Trial to test the effect of administering N-acetylcysteine on cytokines and markers of oxidant stress and the incidence of acute renal failure post liver tranplant
What is the current status of trial NCT01907061?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2007-07. Estimated completion is 2014-07.
What conditions does trial NCT01907061 study?
This clinical trial studies the following conditions: Acute Renal Failure.
What interventions are being tested in trial NCT01907061?
The interventions under investigation include: Placebo (DRUG), N-acetylcysteine (DRUG).
Who is sponsoring clinical trial NCT01907061?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01907061 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Renal Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Does Detailed Informed Consent for Cardiopulmonary Resuscitation and Mechanical Ventilation Impact Patients' Decisions and Outcomes?
COMPLETED · NA
-
Low Dose Thymoglobin in Renal Transplant Patients
COMPLETED · NA
-
Kidney Precision Medicine Project
RECRUITING
-
Prevention Of Nephrotoxicity Following Bone Marrow Transplantation Using Urodilatin and Mannitol
COMPLETED · Phase 2
-
Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.